FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * Lundberg Theodore B. 2. Issuer Name and Ticker or Trading Symbol AdaptHealth Corp. [ AHCO ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)__X__ Director                    _____ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)         (First)         (Middle)
C/O ADAPTHEALTH CORP., 220 W. GERMANTOWN PIKE, SUITE 250
3. Date of Earliest Transaction (MM/DD/YYYY)
8/23/2021
(Street)
PLYMOUTH MEETING, PA 19462
(City)       (State)       (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock  8/23/2021    A    4509 (1) A $0  4509  D   
Common Stock                 6680833  I  See footnote (2)
Common Stock                 634347  I  See footnote (3)
Common Stock                 2142163  I  See footnote (4)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
(1)  Represents a grant of restricted stock to the Reporting Person, a director of the Issuer. The proceeds of any sale of these shares will be transferred to Peloton Equity, LLC and as such, the Reporting Person disclaims ownership of such shares reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein, if any.
(2)  Shares held by Peloton AeroCare SPV I, L.P. ("Peloton AeroCare I"). Peloton Equity GP, LLC ("Peloton Equity GP") is the general partner of Peloton AeroCare I. The Reporting Person is a managing member of Peloton Equity GP, and disclaims beneficial ownership of the shares held by Peloton AeroCare I except to the extent of his pecuniary interest therein, if any. Includes 3,214,007 shares of Common Stock received upon the conversion of Series C Preferred Stock on March 18, 2021.
(3)  Shares held by Peloton AeroCare SPV II, L.P. ("Peloton AeroCare II"). Peloton Equity GP is the general partner of Peloton AeroCare II. The Reporting Person is a managing member of Peloton Equity GP, and disclaims beneficial ownership of the shares held by Peloton AeroCare II except to the extent of his pecuniary interest therein, if any. Includes 306,087 shares of Common Stock received upon the conversion of Series C Preferred Stock on March 18, 2021.
(4)  Shares held by Peloton Equity I, L.P. ("Peloton Equity I"). Peloton Equity GP is the general partner of Peloton Equity I. The Reporting Person is a managing member of Peloton Equity GP, and disclaims beneficial ownership of the shares held by Peloton Equity I except to the extent of his pecuniary interest therein, if any. Includes 1,033,644 shares of Common Stock received upon the conversion of Series C Preferred Stock on March 18, 2021.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Lundberg Theodore B.
C/O ADAPTHEALTH CORP.
220 W. GERMANTOWN PIKE, SUITE 250
PLYMOUTH MEETING, PA 19462
X



Signatures
/s/ Theodore B. Lundberg*** 8/25/2021
**Signature of Reporting Person Date
AdaptHealth (NASDAQ:AHCO)
Historical Stock Chart
From Dec 2021 to Jan 2022 Click Here for more AdaptHealth Charts.
AdaptHealth (NASDAQ:AHCO)
Historical Stock Chart
From Jan 2021 to Jan 2022 Click Here for more AdaptHealth Charts.